Introduction. Endovascular revascularization is a peripheral artery disease
therapy used to improve blood flow in blood vessels. The objective of this
study was to analyze the types and prevalence of comorbidities in patients
with indications for carotid artery revascularization, as well as early
results of endovascular carotid artery revascularization in relation to
periprocedural complications. Material and Methods. This retrospective study
was conducted from October 2014 to October 2019 and included 96 patients.
Descriptive and comparative statistical analysis was performed in all
patients, male and female, and those with both symptomatic and asymptomatic
carotid diseases. Results. The study included 96 patients, of whom 69.8%
were male and 30.2% were female. A successful endovascular procedure was
performed in 89.6% of patients, while in 10.4% of patients the procedure
failed. The distribution of patients by sex, age and the duration of
procedure, showed a statistically significant difference (p < 0.05) in the
age (p = 0.0003) and duration of the procedure (p = 0.022). The comparison
of two groups of patients, with symptomatic and asymptomatic carotid
atherosclerotic disease, hyperlipoproteinemia (p = 0.015) showed a
statistically significant difference (p < 0.05) between the two groups.
Conclusion. Endovascular revascularization has a high success rate in the
treatment of atherosclerotic disease of the carotid arteries as well as low
periprocedural morbidity and mortality. The analysis of gender-related
differences, we concluded that endovascular revascularization lasts
significantly longer in female patients, and that the average age is
significantly higher in male patients compared to females. We also concluded
that hyperlipoproteinemia is a major risk factor for carotid artery disease.
PC054. Association Between Carotid Artery Stenosis and Atherosclerotic Disease Risk Score in a Screening Ultrasound Population
